首页> 外文期刊>Acta Neurochirurgica >The perioperative use of oral anticoagulants during surgical procedures for carpal tunnel syndrome. A preliminary study.
【24h】

The perioperative use of oral anticoagulants during surgical procedures for carpal tunnel syndrome. A preliminary study.

机译:腕管综合症手术过程中围手术期口服抗凝剂的使用。初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: To evaluate the feasibility of designing a randomized controlled study whether open carpal tunnel release (OCTR) surgery can be performed safely under systemic anticoagulant therapy using acetylsalicylacid (ASA) or acenocoumarol (ACM), this preliminary, observational study was performed. METHODS: Prospectively, during 1 year, data were collected from all patients who underwent conventional OCTR at the neurosurgical department of the Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. Patients continued anticoagulant treatment perioperatively. RESULTS: A total of 364 patients were operated on, of whom 45 continued ASA and seven ACM treatment. Only one patient using ASA complained of a postoperative subcutaneous hemorrhage. In the control group without anticoagulants, none of the patients had a bleeding postoperatively. CONCLUSION: Continuation of anticoagulant treatment is safe for OCTR. The adverse effects of stopping treatment for surgery can be severe. As a result of this study, we have changed our surgery protocol for OCTR and continue anticoagulant treatment perioperatively.
机译:背景:为了评估设计随机对照研究是否可行,可以使用乙酰水杨酸(ASA)或乙酰香豆酚(ACM)在全身抗凝治疗下安全地进行开放腕管松开(OCTR)手术,这项初步的观察性研究进行了。方法:前瞻性地,在1年中,收集了荷兰奈梅亨Canisius Wilhelmina医院神经外科所有接受常规OCTR的患者的数据。患者在围手术期继续抗凝治疗。结果:总共进行了364例手术,其中45例继续进行ASA和7例进行ACM治疗。只有一名使用ASA的患者抱怨术后皮下出血。在没有抗凝剂的对照组中,没有患者术后出血。结论:继续抗凝治疗对OCTR是安全的。停止手术治疗的不利影响可能很严重。这项研究的结果是,我们改变了OCTR的手术方案,并在围手术期继续进行抗凝治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号